Filed: 8/14/2026ACC: 0001104659-26-096405
📋 What this filing means
FAIRMOUNT FUNDS MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $1.51B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$1.51B
Total AUM (reported)
46.71M
Total Shares
Allocation by class
COM$1.15B76.0%
COM NEW$363.36M24.0%
Portfolio Concentration
Top 3$826.58M54.6%
4–10$650.83M43.0%
11–25$35.56M2.4%
Top 3 weight
54.6%
Top 10 weight
97.6%
Voting Authority Distribution
Total shares with voting rights: 46.71M
Sole
Full voting authority
46.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
ORUKA THERAPEUTICS INC
SOLEShares3.71M
TypeSH
Market value$352.63M
23.31%
Sole
3.71M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares2.54M
TypeSH
Market value$247.33M
16.35%
Sole
2.54M
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares8.71M
TypeSH
Market value$226.63M
14.98%
Sole
8.71M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.50M
TypeSH
Market value$212.98M
14.08%
Sole
5.50M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares4.55M
TypeSH
Market value$101.18M
6.69%
Sole
4.55M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares1.86M
TypeSH
Market value$94.17M
6.22%
Sole
1.86M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares5.09M
TypeSH
Market value$93.52M
6.18%
Sole
5.09M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares2.36M
TypeSH
Market value$59.87M
3.96%
Sole
2.36M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares2.75M
TypeSH
Market value$49.46M
3.27%
Sole
2.75M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares298.65K
TypeSH
Market value$39.64M
2.62%
Sole
298.65K
Shared
0.00
None
0.00
FAETH THERAPEUTICS INC
SOLEShares722.02K
TypeSH
Market value$18.05M
1.19%
Sole
722.02K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares8.63M
TypeSH
Market value$17.51M
1.16%
Sole
8.63M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ORUKA THERAPEUTICS INCSOLE | COM | 3.71M | SH | $352.63M 23.31% | 3.71M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 2.54M | SH | $247.33M 16.35% | 2.54M | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | COM NEW | 8.71M | SH | $226.63M 14.98% | 8.71M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.50M | SH | $212.98M 14.08% | 5.50M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 4.55M | SH | $101.18M 6.69% | 4.55M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 1.86M | SH | $94.17M 6.22% | 1.86M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 5.09M | SH | $93.52M 6.18% | 5.09M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 2.36M | SH | $59.87M 3.96% | 2.36M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 2.75M | SH | $49.46M 3.27% | 2.75M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 298.65K | SH | $39.64M 2.62% | 298.65K | 0.00 | 0.00 |
FAETH THERAPEUTICS INCSOLE | COM NEW | 722.02K | SH | $18.05M 1.19% | 722.02K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 8.63M | SH | $17.51M 1.16% | 8.63M | 0.00 | 0.00 |